A neuropatia diabética periférica (NDP) é uma complicação comum e grave que afeta 50% das pessoas com diabetes. Neste estudo, avaliamos os efeitos da ALC (aminoácido acetil L‐carnitina )para o tratamento da NDP. https://t.co/aI2mu0C5gY https://t.co/oMvKbMC
RT @FarmaMadridAP: (Cochrane) Revisión sistemática sobre acetil-L-carnitina en neuropatía diabética. Incertidumbre. Evidencia escasa y de p…
RT @FarmaMadridAP: (Cochrane) Revisión sistemática sobre acetil-L-carnitina en neuropatía diabética. Incertidumbre. Evidencia escasa y de p…
(Cochrane) Revisión sistemática sobre acetil-L-carnitina en neuropatía diabética. Incertidumbre. Evidencia escasa y de poca calidad. https://t.co/FkxEs1UciY
L’Acétyl-L-carnitine pour le traitement de la neuropathie diabétique https://t.co/GOGUKu8iOr
Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. - PubMed - NCBI https://t.co/pWuaZpOJNI
RT @MitochondriaNe1: #mitochondria Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. https://t.co/D2titzqFmu via @Mit…
#mitochondria Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. https://t.co/D2titzqFmu via @MitochondriaNe1
Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. https://t.co/wBGHJHevQj
Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy - Rolim, LCSP - 2019 | Cochrane Library https://t.co/mqDuRWF6pC https://t.co/dC6bt3oNBK
Acetyl-L-carnitine for the treatment of diabetic neuropathy https://t.co/9S8Mw6I593 via @instapaper